AstraZeneca PLC (AZN)
204.20
-4.42
(-2.12%)
USD |
NYSE |
Feb 20, 16:00
204.29
+0.09
(+0.04%)
After-Hours: 20:00
AstraZeneca SG&A Expense (Quarterly) : 152.78M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| GSK Plc | 3.510B |
| Mereo BioPharma Group Plc | 6.009M |
| Regeneron Pharmaceuticals, Inc. | 775.00M |
| Biodexa Pharmaceuticals Plc | -- |
| Bicycle Therapeutics Plc | 18.74M |